Drug Profile
Research programme: macrolide therapeutics - NB Health Laboratory
Alternative Names: P 008Latest Information Update: 28 Oct 2020
Price :
$50
*
At a glance
- Originator NB Health Laboratory
- Class Macrolides
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes - Chronic obstructive pulmonary disease; Sinusitis
Highest Development Phases
- No development reported Chronic obstructive pulmonary disease; Sinusitis
Most Recent Events
- 28 Oct 2020 No recent reports of development identified for research development in Chronic-obstructive-pulmonary-disease in Japan
- 28 Oct 2020 No recent reports of development identified for research development in Sinusitis in Japan
- 13 Sep 2016 New profile created from NB Health laboratory pipeline, September 2016